GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mangalam Drugs & Organics Ltd (BOM:532637) » Definitions » Debt-to-Revenue

Mangalam Drugs & Organics (BOM:532637) Debt-to-Revenue : 0.00 (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Mangalam Drugs & Organics Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Mangalam Drugs & Organics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0 Mil. Mangalam Drugs & Organics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0 Mil. Mangalam Drugs & Organics's annualized Revenue for the quarter that ended in Dec. 2023 was ₹3,882 Mil. Mangalam Drugs & Organics's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.00.


Mangalam Drugs & Organics Debt-to-Revenue Historical Data

The historical data trend for Mangalam Drugs & Organics's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mangalam Drugs & Organics Debt-to-Revenue Chart

Mangalam Drugs & Organics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.18 0.18 0.20 N/A 0.27

Mangalam Drugs & Organics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A - 0.27 - 0.24

Competitive Comparison of Mangalam Drugs & Organics's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Mangalam Drugs & Organics's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mangalam Drugs & Organics's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mangalam Drugs & Organics's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Mangalam Drugs & Organics's Debt-to-Revenue falls into.



Mangalam Drugs & Organics Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Mangalam Drugs & Organics's Debt-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(800.046 + 184.879) / 3673.536
=0.27

Mangalam Drugs & Organics's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 0) / 3881.836
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2023) Revenue data.


Mangalam Drugs & Organics Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Mangalam Drugs & Organics's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Mangalam Drugs & Organics (BOM:532637) Business Description

Traded in Other Exchanges
Address
239, P. D’Mello Road, Rupam Building, 3rd Floor, Near General Post Office, Mumbai, MH, IND, 400001
Mangalam Drugs & Organics Ltd is an Indian company operating in the healthcare sector. It is engaged in the research and development and manufacturing of drugs. Its product range includes Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty chemicals. Its sales comprise of sales in the Indian and overseas markets.

Mangalam Drugs & Organics (BOM:532637) Headlines

No Headlines